Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec to Acquire Just Biotherapeutics in $90M Transaction | Contract Pharma

What are you searching for?

Sign in
Breaking News

Evotec to Acquire Just Biotherapeutics in $90M Transaction

Expands therapeutic offerings in areas such as oncology, CNS, pain, inflammation, metabolics, and infectious diseases

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec SE has signed a definitive agreement to acquire Just Biotherapeutics, Inc., based in Seattle, WA, for as much as $90 million in cash, including potential performance-based earn-out components expected within the next three years.

Just.Bio is a technology company that integrates highly synergistic scientific expertise and technologies for design, development, and manufacturing of biologics. The acquisition expands Evotec’s service offering including biologics in therapeutic areas such as oncology, CNS, pain, inflammation, metabolics, and infectious diseases. Just.Bio has approx. 90 employees, mainly scientists, all working at a state-of-the-art discovery, development and manufacturing facility in Seattle.

The transaction, subject to customary closing conditions, is expected to close in 2Q19.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters